Schwarz S, Zhou G Z, Katki A G, Rodbard D
Institute of General and Experimental Pathology, Faculty of Medicine, University of Innsbruck, Austria.
Neuroscience. 1990;37(1):193-200. doi: 10.1016/0306-4522(90)90204-h.
Rat brain synaptosomal membranes that are depleted of endogenous excitatory amino acids cannot bind [(+)-5-methyl-10, 11-dihydro-5H-dibenzo(a,d]cyclohept-5,10-imine maleate] ([3H]MK-801). However, they do so upon the restoration of excitatory amino acid agonists such as L-glutamate. [3H]MK-801 provides a molecular probe which is specific for a binding site located within the ionophore of the N-methyl-D-aspartate-type excitatory amino acid receptor, [3H]MK-801 does not bind to non-N-methyl-D-aspartate excitatory amino acid receptors. Exploiting [3H]MK-801 binding as a quantitative measure of agonist activity with respect to ability of inducing the open channel conformation, the present study demonstrates that L-homocysteate is an agonist almost equivalent to L-glutamate in terms of efficacy (maximal N-methyl-D-aspartate response) as well as potency (EC50). The effect of L-homocysteate was dose-dependent, stereospecific (L-homocysteate greater than DL-homocysteate greater than D-homocysteate), suppressible by the N-methyl-D-aspartate-selective competitive antagonist (+/-)-3(2-carboxy-piperazine-4-yl)propyl-l-phosphonate, and potentiated by the N-methyl-D-aspartate-selective "allosteric" modulator glycine. The demonstrated inactivity of L-homocysteine (and virtually all naturally occurring, non-acidic amino acids) implies that the omega-sulphonic acid moiety is an acceptable substitute for the omega carboxyl group for activating the N-methyl-D-aspartate receptor. While the potency of L-homocysteate at N-methyl-D-aspartate receptors was by a factor of only 1.6 smaller than that of L-glutamate, the affinity of L-homocysteate for kainate-type excitatory amino acid receptors was approximately four-fold lower than that of L-glutamate.(ABSTRACT TRUNCATED AT 250 WORDS)
去除内源性兴奋性氨基酸的大鼠脑突触体膜不能结合[(+)-5-甲基-10,11-二氢-5H-二苯并[a,d]环庚-5,10-亚胺马来酸盐]([3H]MK-801)。然而,当恢复兴奋性氨基酸激动剂如L-谷氨酸时,它们就能够结合。[3H]MK-801提供了一种分子探针,它对位于N-甲基-D-天冬氨酸型兴奋性氨基酸受体离子载体内的一个结合位点具有特异性,[3H]MK-801不与非N-甲基-D-天冬氨酸兴奋性氨基酸受体结合。利用[3H]MK-801结合作为激动剂活性关于诱导开放通道构象能力的定量指标,本研究表明,就效力(最大N-甲基-D-天冬氨酸反应)以及效价(半数有效浓度)而言,L-高半胱氨酸是一种几乎与L-谷氨酸等效的激动剂。L-高半胱氨酸的作用呈剂量依赖性、立体特异性(L-高半胱氨酸大于DL-高半胱氨酸大于D-高半胱氨酸),可被N-甲基-D-天冬氨酸选择性竞争性拮抗剂(+/-)-3(2-羧基-哌嗪-4-基)丙基-1-膦酸盐抑制,并被N-甲基-D-天冬氨酸选择性“变构”调节剂甘氨酸增强。所证明的L-高半胱氨酸(以及几乎所有天然存在的非酸性氨基酸)无活性意味着ω-磺酸部分是激活N-甲基-D-天冬氨酸受体的ω-羧基的可接受替代物。虽然L-高半胱氨酸在N-甲基-D-天冬氨酸受体上的效价比L-谷氨酸仅小1.6倍,但L-高半胱氨酸对海人藻酸型兴奋性氨基酸受体的亲和力比L-谷氨酸低约四倍。(摘要截短于250字)